GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hologic, Inc. (HOLX) [hlAlert]

Rating:
Buy HOLX
up 101.79 %

Hologic, Inc. (HOLX) upgraded to Buy with price target $24 by Brigantine

Posted on: Tuesday,  Feb 1, 2011  8:25 AM ET by Brigantine

Brigantine rated Buy Hologic, Inc. (NASDAQ: HOLX) on 02/01/2011, when the stock price was $19.48. Since
then, Hologic, Inc. has gained 101.80% as of 01/28/2016's recent price of $39.31.
If you would have followed this Brigantine's recommendation on HOLX, you would have gained 101.79% of your investment in 1822 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Brigantine Advisors is an integrated research team with its first focus on the technology sector. The equity research analysts on our team began their careers in industry with most spending an average of 7 years in their respective sectors. In addition, each analyst has spent over 10 plus years on Wall Street and collectively they have over 100 years of experience. We provide our investment clients timely analysis of market trends by identifying major technology shifts. Within the macro environment, we identify profitable investment opportunities with a focus on both the financial and technical capabilities of the companies we analyze.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2011 8:25 AM Buy
None
19.48 24.00
as of 12/30/2011
1 Week up  1.21 %
1 Month down  -0.56 %
3 Months up  15.12 %
1 YTD down  -10.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2010 1:25 PM Hold
None
16.27 17.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy